US7771719B1
(en)
|
2000-01-11 |
2010-08-10 |
Genentech, Inc. |
Pharmaceutical compositions, kits, and therapeutic uses of antagonist antibodies to IL-17E
|
US20040058355A1
(en)
|
1998-09-30 |
2004-03-25 |
Millennium Pharmaceuticals, Inc. |
Novel 21910, 56634, 55053, 2504, 15977, 14760, 25501, 17903, 3700, 21529, 26176, 26343, 56638, 18610, 33217, 21967, H1983, M1983, 38555 or 593 molecules and uses therefor
|
US7001752B1
(en)
|
1999-05-28 |
2006-02-21 |
Immunex Corporation |
Murine and human kinases
|
EP1181374A4
(de)
|
1999-05-28 |
2003-04-23 |
Immunex Corp |
Neue kinasen aus maus und mensch
|
KR100543857B1
(ko)
*
|
1999-09-01 |
2006-01-23 |
제넨테크, 인크. |
혈관신생 및 심혈관형성의 촉진 또는 억제
|
JP2003528581A
(ja)
*
|
1999-09-24 |
2003-09-30 |
レキシコン・ジェネティクス・インコーポレーテッド |
プロテアーゼ阻害物質様の新規ヒトタンパク質およびそれをコードするポリヌクレオチド
|
CA2391805A1
(en)
*
|
1999-10-06 |
2001-04-12 |
The Regents Of The University Of California |
Differentially expressed genes associated with her-2/neu overexpression
|
US6770477B1
(en)
|
1999-10-06 |
2004-08-03 |
The Regents Of The University Of California |
Differentially expressed genes associated with HER-2/neu overexpression
|
EP2290081A3
(de)
*
|
1999-12-23 |
2012-08-01 |
Genentech, Inc. |
IL-17-homologe Polypeptide und ihre therapeutische Verwendung
|
WO2001059114A2
(en)
*
|
2000-02-09 |
2001-08-16 |
The Government Of The United States Of America, As Represented By The Secretary Of Health And Human Services |
Tumor suppressor gene, p47ing3
|
WO2001064905A2
(en)
*
|
2000-02-29 |
2001-09-07 |
Millennium Pharmaceuticals, Inc. |
2504, 15977, and 14760, novel protein kinase family members and uses therefor
|
JP2003526370A
(ja)
*
|
2000-03-16 |
2003-09-09 |
アムジェン インコーポレーテッド |
Il−17レセプター様分子およびその使用
|
EP1283255A4
(de)
*
|
2000-04-27 |
2004-12-29 |
Kyowa Hakko Kogyo Kk |
Myokardzellenproliferation-assoziierte gene
|
US20010049106A1
(en)
*
|
2000-04-27 |
2001-12-06 |
Leonard Buckbinder |
ADAMTS polypeptides, nucleic acids encoding them, and uses thereof
|
AU2001259450A1
(en)
*
|
2000-05-05 |
2001-11-20 |
Incyte Genomics, Inc. |
Cytoskeleton-associated proteins
|
EP1290186A2
(de)
*
|
2000-05-31 |
2003-03-12 |
Bayer Aktiengesellschaft |
Regulation eines humanen transketolase-ähnlichen enzyms
|
US20030096969A1
(en)
|
2000-06-02 |
2003-05-22 |
Genentech, Inc. |
Secreted and transmembrane polypeptides and nucleic acids encoding the same
|
EP1254912A1
(de)
*
|
2001-04-30 |
2002-11-06 |
Boehringer Ingelheim International GmbH |
CYK-4 Polypeptide, dafür kodierende DNS Moleküle und deren Verwendung in Screeningverfahren
|
AU2001269078A1
(en)
*
|
2000-06-19 |
2002-01-02 |
Boehringer Ingelheim International G.M.B.H |
Cyk-4 polypeptides, dna molecules encoding them and their use in screening methods
|
US20030105288A1
(en)
*
|
2000-07-25 |
2003-06-05 |
Genentech, Inc. |
Secreted and transmembrane polypeptides and nucleic acids encoding the same
|
US6534309B1
(en)
*
|
2000-08-03 |
2003-03-18 |
Cytokinetics, Inc. |
Motor proteins and methods for their use
|
AU2001292769A1
(en)
*
|
2000-09-20 |
2002-04-02 |
Pe Corporation (Ny) |
Isolated human transporter proteins, nucleic acid molecules encoding them, and uses thereof
|
AU2001294741A1
(en)
*
|
2000-09-25 |
2002-04-02 |
Millennium Pharmaceuticals, Inc. |
3700, a novel human protein kinase and uses therefor
|
TW499433B
(en)
|
2000-12-27 |
2002-08-21 |
Ind Tech Res Inst |
Novel human Α1-chain collagen
|
US20030104385A1
(en)
*
|
2001-08-02 |
2003-06-05 |
Evans Glen A. |
Nucleic acids and encoded polypeptides associated with bipolar disorder
|
NZ531570A
(en)
*
|
2001-09-27 |
2006-03-31 |
Bionomics Ltd |
DNA sequences for human angiogenesis genes
|
AU2002328200B2
(en)
*
|
2001-09-27 |
2008-01-03 |
Bionomics Limited |
DNA sequences for human angiogenesis genes
|
ATE451387T1
(de)
*
|
2001-12-18 |
2009-12-15 |
Endocube Sas |
Neue mit dem zelltod assoziierte proteine aus der thap familie und par4 verwandte signalwege, die bei der kontrolle von apoptosis involviert sind
|
US7858297B2
(en)
|
2001-12-18 |
2010-12-28 |
Centre National De La Recherche Scientifique Cnrs |
Chemokine-binding protein and methods of use
|
JP2004097199A
(ja)
*
|
2002-07-15 |
2004-04-02 |
Keio Gijuku |
腫瘍抗原のスクリーニング方法
|
JPWO2004015110A1
(ja)
*
|
2002-08-07 |
2005-12-02 |
独立行政法人産業技術総合研究所 |
糖鎖合成遺伝子
|
AU2003257633A1
(en)
*
|
2002-08-21 |
2004-03-11 |
Mitsuhiro Okamoto |
Salt-inducible kinases 2 and use thereof
|
EP1578364A4
(de)
*
|
2002-09-16 |
2011-06-08 |
Genentech Inc |
Zusammensetzungen und verfahren zur behandlung von erkrankungen des immunsystems
|
ATE335816T1
(de)
|
2002-09-18 |
2006-09-15 |
Sirs Lab Gmbh |
Verfahren zum nachweis prokaryontischer dna
|
AU2003269557A1
(en)
*
|
2002-10-18 |
2004-05-04 |
Lg Life Sciences Ltd. |
Gene families associated with cancers
|
US7423018B2
(en)
*
|
2002-12-13 |
2008-09-09 |
University Of Massachusetts |
Kinesin-like proteins and methods of use
|
US7632640B2
(en)
*
|
2003-12-08 |
2009-12-15 |
The Clinic For Special Children |
Association of TSPYL polymorphisms with SIDDT syndrome
|
DK1723233T3
(da)
*
|
2004-03-05 |
2012-07-23 |
Sirs Lab Gmbh |
Fremgangsmåde til berigelse og/eller adskillelse prokaryotisk DNA ved hjælp af et protein, som specifikt binder DNA indeholdende ikke-methylerede CPG-motiver
|
WO2005089429A2
(en)
*
|
2004-03-17 |
2005-09-29 |
University Of Virginia Patent Foundation |
Sfec, a sperm flagellar energy carrier protein
|
JP4468989B2
(ja)
|
2004-08-16 |
2010-05-26 |
クアーク・ファーマスーティカルス、インコーポレイテッド |
Rtp801阻害剤の治療への使用
|
US20110177079A1
(en)
*
|
2004-09-08 |
2011-07-21 |
Ludwig Institute For Cancer Research |
Cancer-testis antigens
|
US7332591B2
(en)
*
|
2004-12-21 |
2008-02-19 |
The University Of Iowa Research Foundation |
Bardet-Biedl susceptibility gene and uses thereof
|
US7825099B2
(en)
|
2006-01-20 |
2010-11-02 |
Quark Pharmaceuticals, Inc. |
Treatment or prevention of oto-pathologies by inhibition of pro-apoptotic genes
|
DOP2007000015A
(es)
|
2006-01-20 |
2007-08-31 |
Quark Biotech Inc |
Usos terapéuticos de inhibidores de rtp801
|
WO2008054534A2
(en)
|
2006-05-11 |
2008-05-08 |
Quark Pharmaceuticals, Inc. |
Screening systems utilizing rtp801
|
EP2026843A4
(de)
|
2006-06-09 |
2011-06-22 |
Quark Pharmaceuticals Inc |
Therapeutische verwendungen von rtp801l
|
JP2010518880A
(ja)
|
2007-02-26 |
2010-06-03 |
クアーク・ファーマスーティカルス、インコーポレイテッド |
Rtp801のインヒビター及びその疾患の治療における使用
|
US8614311B2
(en)
|
2007-12-12 |
2013-12-24 |
Quark Pharmaceuticals, Inc. |
RTP801L siRNA compounds and methods of use thereof
|
US20090317400A1
(en)
|
2008-05-05 |
2009-12-24 |
Krzysztof Masternak |
Anti-IL 17A/IL-17F Cross-Reactive Antibodies and Methods of Use Thereof
|
WO2010108926A1
(en)
*
|
2009-03-24 |
2010-09-30 |
Inserm (Institut National De La Sante Et De La Recherche Medicale) |
Method for diagnosing or predicting a non syndromic autosomal recessive optic atrophy, or a risk of a non syndromic autosomal recessive optic atrophy.
|
MX2011011729A
(es)
|
2009-05-05 |
2012-04-10 |
Novimmune Sa |
Anticuerpo anti il-17f y metodos de uso de los mismos.
|
CN103421742B
(zh)
*
|
2013-05-31 |
2015-01-28 |
华中农业大学 |
抗伏马菌素b1的单克隆重组抗体h2
|
CN103421743B
(zh)
*
|
2013-05-31 |
2015-01-28 |
华中农业大学 |
抗伏马菌素b1的单克隆重组抗体h7
|
DE102020210725A1
(de)
*
|
2019-10-31 |
2021-05-06 |
Gelita Ag |
Ernährungsphysiologisch optimiertes Kollagenpeptid
|